Japanese Government Procurement

National University Corporation - Notice of Procurement (Goods & Services)A Lenalidomide Hydrate 5㎎ (40capsules/1case) 396 cases,Ｂ　Nusinersen Sodium (12㎎／5㎖／1vial) 2 vials,Ｃ　Onasemnogene abeparvovec 1 Set,Ｄ　Human (allogeneic) mesenchymal stem cells derived from bone marrow 72 bags,Ｅ　Tisagenlecleucel 12 Set,Ｆ　Lisocabtagene maraleucel 9 Set,Ｇ　idecabtagen...

This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.

Japanese

Publishing date Feb 01, 2024
Type of notice Notice of Procurement (Goods & Services)
Procurement entity National University Corporation - Chiba
Classification
0004 Medical & Pharmaceutical Products
Summay of notice ⑴ Official in charge of disbursement of the procuring entity : Hiroshi Maruyama, The Obligating Officer Administration Bureau, Chiba University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Lenalidomide Hydrate 5㎎ (40capsules/1case) 396 cases
B Nusinersen Sodium (12㎎/5㎖/1vial) 2 vials
C Onasemnogene abeparvovec 1 Set
D Human (allogeneic) mesenchymal stem cells derived from bone marrow 72 bags
E Tisagenlecleucel 12 Set
F Lisocabtagene maraleucel 9 Set
G idecabtagene vicleucel 9 Set
H Axicabtagene Ciloleucel 1 Set
⑷ Delivery period : From 1 April, 2024 through 31 March, 2025
⑸ Delivery place : Chiba University Hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 5 and 6 of the Regulation concerning the Contract for Chiba University, Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause,
B have the Grade A or Grade B qualification during fiscal 2024 in the Kanto・Koshinetsu area in sales of product for participating in tenders by Single qualification for every ministry and agency, or in tenders by National University Corporation,
C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,
D prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by the Obligating Officer,
E meet the qualification requirements which The Obligating Officer, Administration Bureau, may specify in accordance with Article 7 of the Regulation,
F not be currently under a suspension of business order as instructed by The Obligating Officer.
⑺ Time limit of tender : 14 : 00, 25 March, 2024
⑻ Contact point for the notice : Yoshihiro Kakinuma, Procurement Section, Management Division, Chiba University Hospital, 1-8-1 Inohana Chuo-ku Chiba-shi 260-8677 Japan, TEL 043-226-2682
⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.